Serum Institute Of India Covishield
-
{
- All
- News
- Videos
-
Serum Institute Restarts Production Of Covishield Vaccine After Cases Rise
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
Serum Institute To Supply Nearly 22 Crore Vaccine Doses To Centre In Oct: Report
Serum Institute has informed the Centre that it will be able to supply around 22 crore doses of Covishield in October as the Centre announced that the export of surplus Covid vaccines will resume in the coming fourth quarter, sources said.
-
Serum Institute Chairman Cyrus Poonawalla On Taking Third Covishield Dose
The ideal gap between two doses of Covishield is two months and another dose of the vaccine should be taken after six months, the Serum Institute of India (SII) chairman Cyrus Poonawalla said on Friday.
-
Full Advance For Covishield Vaccine Released To Serum On April 28: Centre
The Health Ministry on Monday said that 100 per cent advance of Rs 1732.50 crore was released to the Serum Institute of India on April 28 for 11 crore doses of Covishield vaccine during May, June and July.
-
Serum's Covishield At Rs 400 A Dose For States, 600 For Private Hospitals
Covishield will be sold at Rs 400 a shot to states and Rs 600 to private hospitals, the Serum Institute of India (SII) said today, days ahead of a new round of vaccinations from May 1 that will include all above 18.
-
Court Rejects Move To Stop "Covishield" Trademark Use By Serum Institute
Drug company Cutis Biotech's move to stop the Serum Institute of India from using the trademark "Covishield" has been rejected by a civil court in Pune, the Serum Institute's lawyers said in a note to the media.
-
First Batch Of Serum Vaccines Arrive In Mumbai Under Police Cover
The first batch of 1.39 lakh doses of the Covishield, the Serum Institute of India's coronavirus vaccine, arrived in Mumbai early this morning from Pune.
-
Phase 3 Trial Of Oxford Vaccine To Begin In Pune Next Week
The phase-III human clinical trial of the COVID-19 vaccine developed by Oxford University, and being manufactured by the Serum Institute of India (SII), will begin at the Sassoon General Hospital in Pune next week.
-
Serum Institute Restarts Production Of Covishield Vaccine After Cases Rise
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
Serum Institute To Supply Nearly 22 Crore Vaccine Doses To Centre In Oct: Report
Serum Institute has informed the Centre that it will be able to supply around 22 crore doses of Covishield in October as the Centre announced that the export of surplus Covid vaccines will resume in the coming fourth quarter, sources said.
-
Serum Institute Chairman Cyrus Poonawalla On Taking Third Covishield Dose
The ideal gap between two doses of Covishield is two months and another dose of the vaccine should be taken after six months, the Serum Institute of India (SII) chairman Cyrus Poonawalla said on Friday.
-
Full Advance For Covishield Vaccine Released To Serum On April 28: Centre
The Health Ministry on Monday said that 100 per cent advance of Rs 1732.50 crore was released to the Serum Institute of India on April 28 for 11 crore doses of Covishield vaccine during May, June and July.
-
Serum's Covishield At Rs 400 A Dose For States, 600 For Private Hospitals
Covishield will be sold at Rs 400 a shot to states and Rs 600 to private hospitals, the Serum Institute of India (SII) said today, days ahead of a new round of vaccinations from May 1 that will include all above 18.
-
Court Rejects Move To Stop "Covishield" Trademark Use By Serum Institute
Drug company Cutis Biotech's move to stop the Serum Institute of India from using the trademark "Covishield" has been rejected by a civil court in Pune, the Serum Institute's lawyers said in a note to the media.
-
First Batch Of Serum Vaccines Arrive In Mumbai Under Police Cover
The first batch of 1.39 lakh doses of the Covishield, the Serum Institute of India's coronavirus vaccine, arrived in Mumbai early this morning from Pune.
-
Phase 3 Trial Of Oxford Vaccine To Begin In Pune Next Week
The phase-III human clinical trial of the COVID-19 vaccine developed by Oxford University, and being manufactured by the Serum Institute of India (SII), will begin at the Sassoon General Hospital in Pune next week.
